These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26930420)

  • 1. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.
    Cozzoli A; Rolland JF; Capogrosso RF; Sblendorio VT; Longo V; Simonetti S; Nico B; De Luca A
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):243-56. PubMed ID: 20618838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.
    Ljubicic V; Burt M; Lunde JA; Jasmin BJ
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C66-82. PubMed ID: 24760981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
    Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
    J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Delgado Díaz DC; Kostek MC
    Clin Nutr; 2013 Feb; 32(1):104-11. PubMed ID: 22795790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.
    Camerino GM; Cannone M; Giustino A; Massari AM; Capogrosso RF; Cozzoli A; De Luca A
    Hum Mol Genet; 2014 Nov; 23(21):5720-32. PubMed ID: 24916377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds.
    Gamberi T; Fiaschi T; Valocchia E; Modesti A; Mantuano P; Rolland JF; Sanarica F; De Luca A; Magherini F
    J Proteomics; 2018 Jan; 170():43-58. PubMed ID: 28966053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR; Boyatzis A; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
    Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
    Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice.
    Cozzoli A; Nico B; Sblendorio VT; Capogrosso RF; Dinardo MM; Longo V; Gagliardi S; Montagnani M; De Luca A
    Pharmacol Res; 2011 Nov; 64(5):482-92. PubMed ID: 21689754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lifelong resveratrol supplementation and exercise training on skeletal muscle oxidative capacity in aging mice; impact of PGC-1α.
    Ringholm S; Olesen J; Pedersen JT; Brandt CT; Halling JF; Hellsten Y; Prats C; Pilegaard H
    Exp Gerontol; 2013 Nov; 48(11):1311-8. PubMed ID: 23994519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Decreases Oxidative Stress by Restoring Mitophagy and Improves the Pathophysiology of Dystrophin-Deficient
    Sebori R; Kuno A; Hosoda R; Hayashi T; Horio Y
    Oxid Med Cell Longev; 2018; 2018():9179270. PubMed ID: 30510631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
    Wang XL; Li T; Li JH; Miao SY; Xiao XZ
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging.
    Zarzuelo MJ; López-Sepúlveda R; Sánchez M; Romero M; Gómez-Guzmán M; Ungvary Z; Pérez-Vizcaíno F; Jiménez R; Duarte J
    Biochem Pharmacol; 2013 May; 85(9):1288-96. PubMed ID: 23422569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.